KemPharm Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
133.70
74.80
84.00
175.00
336.00
324
Gross Income
133.70
74.80
84.00
175.00
336.00
324
SG&A Expense
4,584.20
16,368.50
22,730.00
34,297.00
33,030.00
53,943
EBIT
4,717.90
16,443.30
-
-
33,366.00
54,267
Unusual Expense
1,137.30
5,322.60
27,276.00
24,715.00
3,091.00
4,342
Interest Expense
1,716.90
2,715.40
4,580.00
7,127.00
7,337.00
7,087
Pretax Income
5,246.00
24,477.00
54,638.00
16,531.00
43,429.00
56,592
Income Tax
19.50
22.20
26.00
15.00
43.00
126
Consolidated Net Income
5,226.40
24,454.80
54,664.00
16,516.00
43,386.00
56,466
Net Income
5,226.40
24,454.80
54,664.00
16,516.00
43,386.00
56,466
Net Income After Extraordinaries
5,226.40
24,454.80
54,664.00
16,516.00
43,386.00
56,466
Net Income Available to Common
5,226.40
24,454.80
54,664.00
16,516.00
43,386.00
56,466
EPS (Basic)
0.39
1.82
7.42
1.13
2.96
3.15
Basic Shares Outstanding
13,462.70
13,462.70
7,368.70
14,597.10
14,652.90
17,930
EPS (Diluted)
0.39
1.82
7.42
1.13
2.96
3.15
Diluted Shares Outstanding
13,462.70
13,462.70
7,368.70
14,597.10
14,652.90
17,930
EBITDA
4,584.20
16,368.60
22,730.00
34,297.00
33,030.00
53,943
Non-Operating Interest Income
51.40
4.30
32.00
353.00
365.00
420
About KemPharm
View Profile
